FDA Position and Regulatory Status The FDA issued a warning in 2019 highlighting concerns about using dietary ingredient glutathione to compound sterile injectables
It was a small, industry-supported study 12 participants, no placebo group so treat the numbers as a promising direction rather than a guarantee
This is where it gets tricky
Do not use hot liquids because high temperature will denature* (damage) the fragile proteins
Seiwerth, S., Milavi, M., Vukojevi, J., Gojkovic, S., Krezic, I., Vuleti, L., Pavlov, K., Petrovic, A., Sikiri, S., Vrane, H., Prtori, A., Zizek, H., Durasin, T., Dobri, I., Stareini, M., trbe, S., Kneevi, M., ola, M., Kokot, A., Sever, M., Lovri, E., krti, A., Blagaic, A., & Sikiric, P